iSpecimen Inc
ISPC0.388USD
+0.007+1.89%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
3.79MMarket Cap
LossP/E TTM
More Details of iSpecimen Inc Company
iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
iSpecimen Inc Info
Ticker SymbolISPC
Company nameiSpecimen Inc
IPO dateJun 17, 2021
CEOField (Katharyn)
Number of employees24
Security typeOrdinary Share
Fiscal year-endJun 17
Address8 Cabot Road
CityWOBURN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code08101
Phone17813016700
Websitehttps://www.ispecimen.com/
Ticker SymbolISPC
IPO dateJun 17, 2021
CEOField (Katharyn)
Company Executives of iSpecimen Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Specimens – contracts with customers
671.69K
94.19%
Shipping and other
41.44K
5.81%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Specimens – contracts with customers
671.69K
94.19%
Shipping and other
41.44K
5.81%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Renaissance Technologies LLC
1.57%
Virtu Americas LLC
0.65%
OBF Investments LLC
0.43%
Geode Capital Management, L.L.C.
0.43%
Scientech Research LLC
0.30%
Other
96.62%
Shareholders
Shareholders
Proportion
Renaissance Technologies LLC
1.57%
Virtu Americas LLC
0.65%
OBF Investments LLC
0.43%
Geode Capital Management, L.L.C.
0.43%
Scientech Research LLC
0.30%
Other
96.62%
Shareholder Types
Shareholders
Proportion
Hedge Fund
1.59%
Research Firm
0.86%
Investment Advisor
0.63%
Corporation
0.43%
Investment Advisor/Hedge Fund
0.43%
Individual Investor
0.26%
Other
95.80%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
26
96.86K
1.75%
-11.14K
2025Q2
31
133.51K
3.29%
-45.19K
2025Q1
37
201.48K
8.20%
-43.25K
2024Q4
37
175.36K
18.22%
-42.87K
2024Q3
38
178.54K
25.34%
-4.65K
2024Q2
37
155.60K
21.84%
-23.10K
2024Q1
38
168.39K
35.92%
-17.71K
2023Q4
42
174.70K
38.71%
-30.54K
2023Q3
48
208.00K
46.18%
-25.86K
2023Q2
48
208.72K
46.34%
-34.91K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Virtu Americas LLC
--
0%
-2.10K
-100.00%
Sep 30, 2024
OBF Investments LLC
42.10K
0.76%
+1.00
+0.00%
Dec 31, 2024
Geode Capital Management, L.L.C.
14.81K
0.27%
+4.08K
+37.96%
Jun 30, 2025
The Vanguard Group, Inc.
1.24K
0.02%
--
--
Aug 31, 2025
Wolf (James G)
25.25K
0.46%
-14.29K
-36.14%
Jun 03, 2024
BlackRock Institutional Trust Company, N.A.
2.83K
0.05%
--
--
Jun 30, 2025
Tower Research Capital LLC
6.19K
0.11%
+3.21K
+107.51%
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Date
Type
Ratio
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
FAQs
Who are the top five shareholders of iSpecimen Inc?
The top five shareholders of iSpecimen Inc are:
Virtu Americas LLC holds 0.00 shares, accounting for 0.00% of the total shares.
OBF Investments LLC holds 42.10K shares, accounting for 0.76% of the total shares.
Geode Capital Management, L.L.C. holds 14.81K shares, accounting for 0.27% of the total shares.
The Vanguard Group, Inc. holds 1.24K shares, accounting for 0.02% of the total shares.
Wolf (James G) holds 25.25K shares, accounting for 0.46% of the total shares.
Virtu Americas LLC holds 0.00 shares, accounting for 0.00% of the total shares.
OBF Investments LLC holds 42.10K shares, accounting for 0.76% of the total shares.
Geode Capital Management, L.L.C. holds 14.81K shares, accounting for 0.27% of the total shares.
The Vanguard Group, Inc. holds 1.24K shares, accounting for 0.02% of the total shares.
Wolf (James G) holds 25.25K shares, accounting for 0.46% of the total shares.
What are the top three shareholder types of iSpecimen Inc?
The top three shareholder types of iSpecimen Inc are:
Renaissance Technologies LLC
Virtu Americas LLC
OBF Investments LLC
Renaissance Technologies LLC
Virtu Americas LLC
OBF Investments LLC
How many institutions hold shares of iSpecimen Inc (ISPC)?
As of 2025Q3, 26 institutions hold shares of iSpecimen Inc, with a combined market value of approximately 96.86K, accounting for 1.75% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -1.54%.
What is the biggest source of revenue for iSpecimen Inc?
In FY2025Q2, the Specimens – contracts with customers business generated the highest revenue for iSpecimen Inc, amounting to 671.69K and accounting for 94.19% of total revenue.
